Orla Gray

2.8k total citations
14 papers, 265 citations indexed

About

Orla Gray is a scholar working on Pathology and Forensic Medicine, Public Health, Environmental and Occupational Health and Neurology. According to data from OpenAlex, Orla Gray has authored 14 papers receiving a total of 265 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pathology and Forensic Medicine, 4 papers in Public Health, Environmental and Occupational Health and 3 papers in Neurology. Recurrent topics in Orla Gray's work include Multiple Sclerosis Research Studies (10 papers), Autoimmune Neurological Disorders and Treatments (2 papers) and Peripheral Neuropathies and Disorders (2 papers). Orla Gray is often cited by papers focused on Multiple Sclerosis Research Studies (10 papers), Autoimmune Neurological Disorders and Treatments (2 papers) and Peripheral Neuropathies and Disorders (2 papers). Orla Gray collaborates with scholars based in United Kingdom, Australia and Singapore. Orla Gray's co-authors include Gavin McDonnell, Raeburn B Forbes, Helmut Butzkueven, Gary F. Egan, Mark S. Stein, Peter Mitchell, Scott Kolbe, Leonard C. Harrison, Trevor J. Kilpatrick and Michael Ditchfield and has published in prestigious journals such as Neurology, Cochrane Database of Systematic Reviews and JAMA Neurology.

In The Last Decade

Orla Gray

11 papers receiving 256 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Orla Gray United Kingdom	6	181	93	71	39	32	14	265
Josephine Baker Australia	7	187 1.0×	94 1.0×	37 0.5×	28 0.7×	29 0.9×	10	241
Kristin Wesnes Norway	8	216 1.2×	56 0.6×	28 0.4×	39 1.0×	40 1.3×	11	284
Luigina Musu Italy	10	206 1.1×	57 0.6×	55 0.8×	72 1.8×	19 0.6×	10	299
Roberto Bergamaschi Italy	4	171 0.9×	85 0.9×	57 0.8×	52 1.3×	61 1.9×	7	281
Jamie McDonald United States	4	361 2.0×	152 1.6×	78 1.1×	59 1.5×	68 2.1×	4	420
Kimberly M. Winges United States	9	176 1.0×	70 0.8×	74 1.0×	50 1.3×	8 0.3×	14	353
A A Skoromets Russia	5	187 1.0×	70 0.8×	71 1.0×	57 1.5×	20 0.6×	16	259
Paolo Bellantonio Italy	8	171 0.9×	27 0.3×	36 0.5×	37 0.9×	10 0.3×	11	247
David K. Li Canada	7	169 0.9×	32 0.3×	119 1.7×	70 1.8×	19 0.6×	9	332
Patricia Calleja Spain	10	95 0.5×	62 0.7×	68 1.0×	24 0.6×	14 0.4×	16	308

Countries citing papers authored by Orla Gray

Since Specialization

Citations

This map shows the geographic impact of Orla Gray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Orla Gray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Orla Gray more than expected).

Fields of papers citing papers by Orla Gray

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Orla Gray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Orla Gray. The network helps show where Orla Gray may publish in the future.

Co-authorship network of co-authors of Orla Gray

This figure shows the co-authorship network connecting the top 25 collaborators of Orla Gray. A scholar is included among the top collaborators of Orla Gray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Orla Gray. Orla Gray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Dobson, Ruth, Tarunya Arun, James Varley, et al.. (2025). Approach to JCV testing with natalizumab biosimilar: a UK consensus statement. Multiple Sclerosis and Related Disorders. 100. 106541–106541.

McConville, John, Annemarie Hunter, Ailsa Fulton, et al.. (2023). A Neurology Advanced Referral Management System (NARMS) Reduces Face-to-Face Consultations By Over Sixty Percent.. PubMed. 92(1). 19–23. 1 indexed citations

Jokubaitis, Vilija, Olga Skibina, Raed Alroughani, et al.. (2021). The MSBase pregnancy, neonatal outcomes, and women’s health registry. Therapeutic Advances in Neurological Disorders. 14. 4203290192–4203290192. 5 indexed citations

Cruz, Pedro M. Rodríguez, Lucy Matthews, Mike Boggild, et al.. (2016). Time- and Region-Specific Season of Birth Effects in Multiple Sclerosis in the United Kingdom. JAMA Neurology. 73(8). 954–954. 15 indexed citations

Spelman, Tim, Orla Gray, Robyn Lucas, & Helmut Butzkueven. (2015). A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data. Journal of Visualized Experiments. e53169–e53169.

Gray, Orla, et al.. (2015). Symptomatic therapy in multiple sclerosis: Big pharma should do more – NO. Multiple Sclerosis Journal. 21(8). 978–979. 2 indexed citations

Stein, Mark S., Orla Gray, Josephine Baker, et al.. (2011). A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis. Neurology. 77(17). 1611–1618. 136 indexed citations

Spelman, Timothy, et al.. (2011). The effect of pregnancy on relapse rate and disability progression in MS: results from the MSBase Registry. Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna).

Gray, Orla, et al.. (2010). Paraneoplastic sensorimotor neuropathy associated with regression of small cell lung carcinoma. BMJ Case Reports. 2010. bcr0120091486–bcr0120091486. 18 indexed citations

10.

Gray, Orla, David Jolley, Jeannette Lechner‐Scott, et al.. (2009). The Multiple Sclerosis Severity Score (MSSS) re-examined: EDSS rank stability in the MSBase dataset increases 5 years after onset of multiple sclerosis. Multiple Sclerosis Journal. 15(1). 140–140. 3 indexed citations

11.

Gray, Orla & Vincent Van Pesch. (2009). Onset of relapses in multiple sclerosis: the effect of seasonal change in both the northern and southern hemisphere. Multiple Sclerosis Journal. 15(9). 2 indexed citations

12.

Gray, Orla, et al.. (2008). OPSOCLONUS–MYOCLONUS SYNDROME ASSOCIATED WITH BENIGN OVARIAN TERATOMA. Neurology. 70(15). 1292–1293. 19 indexed citations

13.

Gray, Orla, Gavin McDonnell, & Raeburn B Forbes. (2004). Methotrexate for multiple sclerosis. Cochrane Database of Systematic Reviews. 2010(10). CD003208–CD003208. 38 indexed citations

14.

Gray, Orla, Gavin McDonnell, & Raeburn B Forbes. (2003). Intravenous immunoglobulins for multiple sclerosis. Cochrane Database of Systematic Reviews. 2010(2). CD002936–CD002936. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact